Name: Latest research reports of Marico Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Marico Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	01 Feb 2025	Marico	BOB Capital Markets Ltd.	700.85	695.00	694.20 (0.96%)	Target met	Hold	pdf post cache	Broker Report Marico (HOLD): Managing inflation BOB Capital Markets Ltd. Compared to consensus, 3QFY25 sales were 2% lower (1% below our estimate) while EBITDA was 1% pdf Copy Link Share on Share on Share on Share on Alert
	01 Feb 2025	Bandhan Bank	BOB Capital Markets Ltd. Target	165.46	187.00	151.39 (9.29%)	13.02	Buy	pdf post cache	Broker Report Bandhan Bank (BUY): Other income aids PPOP; MFI stress persists BOB Capital Markets Ltd. PPOP aided by one-offs in other income, payouts under CGFMU and Assam Microfinance relief scheme pdf Copy Link Share on Share on Share on Share on Alert
	01 Feb 2025	Nestle	BOB Capital Markets Ltd. Target	2414.40	2470.00	2327.20 (3.75%)	Target met	Hold	pdf post cache	Broker Report Nestle India (HOLD): Managing profits amidst inflation BOB Capital Markets Ltd. NEST continues to manage profits amidst inflation in cocoa and coffee. Wheat and palm have also turned inflationary pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2025	eClerx Services	BOB Capital Markets Ltd.	3356.80	3727.00	3058.15 (9.77%)	11.03	Buy	pdf post cache	Broker Report eClerx Services (BUY): Should be among the faster growing Tier-2 players BOB Capital Markets Ltd. 3QFY25 broadly in line. A margin miss. Expect 4Q QoQ growth to be stronger. Expect low teen USD revenue growth in FY25-FY27. pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2025	Voltas	BOB Capital Markets Ltd. Target	1260.30	1400.00	1260.85 (-0.04%)	Target met	Hold	pdf post cache	Broker Report Voltas (HOLD): Revenue in line with estimates, PAT sees lag BOB Capital Markets Ltd. Topline grew 18% YoY in Q3; EBITDA margin expanded 530bps YoY fueled by better cost efficiencies pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2025	Ajanta Pharma	BOB Capital Markets Ltd. Target	2574.90	2288.00	2694.45 (-4.44%)	11.14	Sell	pdf post cache	Broker Report Ajanta Pharma (SELL): Entering newer therapies to result in higher costs BOB Capital Markets Ltd. AJP reported in-line earnings, sales were 3.6% below estimates, while EBITDA/PAT reported 1%/3% above our estimates pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2025	Dabur	BOB Capital Markets Ltd. Reco Target	481.95	578.00	529.85 (-9.04%)	19.93	Hold	pdf post cache	Broker Report Dabur India (HOLD): Competition and inflation BOB Capital Markets Ltd. Competitive intensity has increased in the domestic business and Dabur is doing retailer discounts to maintain market share pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2025	Tata Consumer	BOB Capital Markets Ltd. Target	1140.80	1175.00	1024.65 (11.34%)	Target met	Buy	pdf post cache	Broker Report Tata Consumer Products (BUY): Staying rational BOB Capital Markets Ltd. Tea inflation recovery prospects have improved as higher pricing has come through earlier than expected pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2025	IDFC First Bank	BOB Capital Markets Ltd. Target	67.09	75.00	56.73 (18.26%)	11.79	Buy	pdf post cache	Broker Report IDFC First Bank (BUY): Subdued performance, elevated provisioning BOB Capital Markets Ltd. Earnings lower on account of higher slippages, moderate loan book growth pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2025	ICICI Bank	BOB Capital Markets Ltd. Reco Target	1449.80	1415.00	1227.95 (18.07%)	Target met	Buy	pdf post cache	Broker Report ICICI Bank (BUY): Continue to demonstrate stable performance BOB Capital Markets Ltd. PAT growth of 15% YoY aided by stable credit cost and PPOP growth of 15% YoY pdf Copy Link Share on Share on Share on Share on Alert
more loading

BOB Capital Markets Ltd. Broker Research reports

Latest broker research reports from BOB Capital Markets Ltd. buy, sell, hold, neutral recommendations along with share price targets forecast and upside.

Marico (HOLD): Managing inflation

Bandhan Bank (BUY): Other income aids PPOP; MFI stress persists

Nestle India (HOLD): Managing profits amidst inflation

eClerx Services (BUY): Should be among the faster growing Tier-2 players

Voltas (HOLD): Revenue in line with estimates, PAT sees lag

Ajanta Pharma (SELL): Entering newer therapies to result in higher costs

Dabur India (HOLD): Competition and inflation

Tata Consumer Products (BUY): Staying rational

IDFC First Bank (BUY): Subdued performance, elevated provisioning

ICICI Bank (BUY): Continue to demonstrate stable performance

Advisor Screeners